Insulin secretagogues, sulfonylurea receptors and K(ATP) channels
- PMID: 16101450
- DOI: 10.2174/1381612054546879
Insulin secretagogues, sulfonylurea receptors and K(ATP) channels
Abstract
ATP-sensitive K+ channels, termed K(ATP) channels, provide a link between cellular metabolism and membrane electrical activity in a variety of tissues. Channel isoforms have been identified and are targets for compounds that both stimulate and inhibit their activity resulting in membrane hyperpolarization and depolarization, respectively. Examples include relaxation of vascular smooth muscle and stimulation of insulin secretion. This article reviews the cloning, molecular biology, and structure of K(ATP) channels, with particular focus on the SUR1/K(IR)6.2 neuroendocrine channels that are important for the regulation of insulin secretion. We integrate the extensive pharmacologic structure-activity-relationship data on these channels, which defines a bipartite drug binding pocket in the SUR (sulfonylurea receptor), with recent structure-function studies that identify domains of SUR and K(IR)6.2, the channel pore, which are critical for channel assembly, for gating, and for the ligand-receptor interactions that modulate channel activity. The atomic structure of a sulfonylurea in a protein pocket is used to develop insight into the recognition of these compounds. A homology model of K(ATP) channels, based on VC-MsbA, another member of the ABC protein family, is described and used to position amino acids important for the action of channel openers and blockers within the core of SUR. The model has a central chamber which could serve as a multifaceted binding pocket.
Similar articles
-
KATP channel openers: structure-activity relationships and therapeutic potential.Med Res Rev. 2004 Mar;24(2):213-66. doi: 10.1002/med.10060. Med Res Rev. 2004. PMID: 14705169 Review.
-
Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.Pharmacol Res. 2007 Sep;56(3):237-47. doi: 10.1016/j.phrs.2007.06.004. Epub 2007 Jun 21. Pharmacol Res. 2007. PMID: 17656102
-
Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.Circulation. 2008 Mar 18;117(11):1405-13. doi: 10.1161/CIRCULATIONAHA.107.745539. Epub 2008 Mar 3. Circulation. 2008. PMID: 18316485
-
Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.Eur J Pharmacol. 2005 Oct 31;523(1-3):109-18. doi: 10.1016/j.ejphar.2005.08.028. Epub 2005 Oct 13. Eur J Pharmacol. 2005. PMID: 16226739
-
Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):11-5. doi: 10.1016/s1056-8727(02)00272-6. J Diabetes Complications. 2003. PMID: 12623163 Review.
Cited by
-
Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.Diabetologia. 2006 Sep;49(9):2039-48. doi: 10.1007/s00125-006-0307-3. Epub 2006 Jul 25. Diabetologia. 2006. PMID: 16865362
-
Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion.Purinergic Signal. 2008 Dec;4(4):393-405. doi: 10.1007/s11302-008-9126-y. Epub 2008 Oct 23. Purinergic Signal. 2008. PMID: 18946723 Free PMC article.
-
Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum.Diabetes Care. 2014 Sep;37(9):2647-59. doi: 10.2337/dc14-1395. Diabetes Care. 2014. PMID: 25147257 Free PMC article.
-
Metabolic cycling in control of glucose-stimulated insulin secretion.Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1287-97. doi: 10.1152/ajpendo.90604.2008. Epub 2008 Aug 26. Am J Physiol Endocrinol Metab. 2008. PMID: 18728221 Free PMC article. Review.
-
The mitochondrial 2-oxoglutarate carrier is part of a metabolic pathway that mediates glucose- and glutamine-stimulated insulin secretion.J Biol Chem. 2010 May 28;285(22):16530-7. doi: 10.1074/jbc.M109.092593. Epub 2010 Mar 31. J Biol Chem. 2010. PMID: 20356834 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical